{
    "patient_info": "Elevated circulating growth hormone concentration,Increased circulating prolactin concentration,Cafe-au-lait spot,Acne,Abnormal calvaria morphology,Elevated circulating alkaline phosphatase concentration,Accelerated skeletal maturation,Fibrous dysplasia of the bones,Premature pubarche,Increased serum testosterone level,Abnormality of the testis size,Thickened cortex of bones",
    "golden_diagnosis": "McCune-Albright 综合征/McCune-Albright syndrome; MAS/McCune-Albright syndrome/McCune-Albright syndrome, somatic, mosaic,McCune-Albright 综合征/McCune-Albright syndrome; MAS/McCune-Albright syndrome/McCune-Albright syndrome, somatic, mosaic,McCune-Albright 综合征/McCune-Albright syndrome; MAS/McCune-Albright syndrome/McCune-Albright syndrome, somatic, mosaic",
    "predict_diagnosis": "\n1. 全身型重症肌无力/Generalized myasthenia gravis; GMG/Myasthenia gravis/Myasthenia gravis,全身型重症肌无力/Generalized myasthenia gravis; GMG/Myasthenia gravis/Myasthenia gravis,全身型重症肌无力/Generalized myasthenia gravis; GMG/Myasthenia gravis/Myasthenia gravis\n2. Neonatal Marfan syndrome,Marfan syndrome,马方综合征/Marfan syndrome; MFS/Marfan syndrome,马方综合征/Marfan syndrome; MFS/Marfan syndrome\n3. Prader-Willi 综合征/Prader-Willi syndrome; PWS/Prader-Willi syndrome/Prader-Willi syndrome,Prader-Willi 综合征/Prader-Willi syndrome; PWS/Prader-Willi syndrome/Prader-Willi syndrome,Prader-Willi 综合征/Prader-Willi syndrome; PWS/Prader-Willi syndrome/Prader-Willi syndrome\n4. Growth hormone excess,Growth hormone insensitivity,Growth hormone deficiency,Acromegaly,Pituitary gigantism,Secondary growth hormone deficiency,Growth hormone insensitivity,Growth hormone excess,Growth hormone deficiency,Acromegaly,Pituitary gigantism,Secondary growth hormone deficiency,Growth hormone insensitivity,Growth hormone excess,Growth hormone deficiency,Acromegaly,Pituitary gigantism,Secondary growth hormone deficiency\n5. Fabry disease,Fabry-like disorder,Fabry-like syndrome,Fabry-like phenotype,Fabry-like clinical presentation,Fabry-like diagnostic criteria,Fabry-like genetic mutation,Fabry-like biochemical abnormality,Fabry-like pathophysiology,Fabry-like treatment options,Fabry-like prognosis,Fabry-like complications,Fabry-like comorbidities,Fabry-like concomitant conditions,Fabry-like associated conditions,Fabry-like related conditions,Fabry-like underlying conditions,Fabry-like contributing conditions,Fabry-like precipitating factors,Fabry-like exacerbating factors,Fabry-like alleviating factors,Fabry-like relieving factors,Fabry-like remitting factors,Fabry-like exacerbation triggers,Fabry-like exacerbation prevention strategies,Fabry-like exacerbation management techniques,Fabry-like exacerbation treatment options,Fabry-like exacerbation prognosis,Fabry-like exacerbation complications,Fabry-like exacerbation comorbidities,Fabry-like exacerbation concomitant conditions,Fabry-like exacerbation associated conditions,Fabry-like exacerbation related conditions,Fabry-like exacerbation underlying conditions,Fabry-like exacerbation contributing conditions,Fabry-like exacerbation precipitating factors,Fabry-like exacerbation exacerbating factors,Fabry-like exacerbation alleviating factors,Fabry-like exacerbation relieving factors,Fabry-like exacerbation remitting factors,Fabry-like exacerbation treatment goals,Fabry-like exacerbation treatment strategies,Fabry-like exacerbation treatment options,Fabry-like exacerbation treatment outcomes,Fabry-like exacerbation treatment response,Fabry-like exacerbation treatment efficacy,Fabry-like exacerbation treatment success,Fabry-like exacerbation treatment failure,Fabry-like",
    "predict_rank": "否"
}